Skip to main content
OpenTrials
Completed

NCT Number: NCT04701372

Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obsessive-Compulsive Disorder Anxiety Disorders Mental Disorders

Age range

10 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Nocd, Llc

Chicago, Illinois, 60601, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • obsessive-compulsive disorder

Exclusion criteria

  • none

Treatment and study plan

Exposure and response prevention therapy

Behavioral

Exposures and response prevention therapy (a type of cognitive-behavioral therapy for obsessive-compulsive disorder), delivered in real-time by licensed therapists remotely via video. The treatment was augmented by between-session text messaging and online community support.

Primary outcomes

  1. Dimensional Obsessive-Compulsive Scale

    Time frame: change from pre-treatment to post-treatment (after 11 weeks)

    self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes

Secondary outcomes

  1. Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) OCD severity scale

    Time frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)

    clinician-rated psychometric instrument to measure overall OCD symptom severity

  2. Depression Anxiety and Stress Scale (DASS-21)

    Time frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)

    self-rated psychometric instrument to measure depression, anxiety, and stress

  3. Quality of Life Enjoyment and Satisfaction Questionnaire -- Short Form (QLES-Q)

    Time frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)

    self-rated psychometric instrument to measure quality of life

Sponsors and collaborators

Lead sponsor

NOCD

Industry

Registry information

Official study title

Clinical Outcomes From NOCD Digital Behavioral Health Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jan 8, 2021
Registry last updated
Jan 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.